379 related articles for article (PubMed ID: 29235470)
1. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
3. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
5. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.
Peng R; Zhang PF; Zhang C; Huang XY; Ding YB; Deng B; Bai DS; Xu YP
Cancer Med; 2018 Mar; 7(3):796-808. PubMed ID: 29446253
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma.
Dong L; Xie L; Li M; Dai H; Wang X; Wang P; Zhang Q; Liu W; Hu X; Zhao M
Sci Rep; 2019 Oct; 9(1):14854. PubMed ID: 31619714
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
9. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
10. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
[TBL] [Abstract][Full Text] [Related]
11. COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma.
Lang Q; Xiao P; Zhao M; Liang D; Meng Q; Pei T
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1247-1256. PubMed ID: 33166992
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
Ohashi T; Eguchi H; Kawamoto K; Konno M; Asai A; Colvin H; Ueda Y; Takaoka H; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Kobayashi S; Koseki J; Satoh T; Ogawa K; Doki Y; Mori M; Ishii H
Oncol Rep; 2018 Mar; 39(3):1276-1282. PubMed ID: 29286150
[TBL] [Abstract][Full Text] [Related]
14. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma.
Cheng R; Chen Y; Zhou H; Wang B; Du Q; Chen Y
APMIS; 2018 May; 126(5):396-402. PubMed ID: 29696716
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
18. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
[TBL] [Abstract][Full Text] [Related]
19. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
Yamaoka R; Ishii T; Kawai T; Yasuchika K; Miyauchi Y; Kojima H; Katayama H; Ogiso S; Fukumitsu K; Uemoto S
J Surg Oncol; 2018 Sep; 118(4):664-674. PubMed ID: 30196535
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival.
Shan ZG; Yan ZB; Peng LS; Cheng P; Teng YS; Mao FY; Fan K; Zhuang Y; Zhao YL
J Immunol Res; 2021; 2021():6613247. PubMed ID: 33763491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
